EP3861011B1: Binders for Inhibiting Multimeric Protein Formation
Summary
The European Patent Office has granted patent EP3861011B1 for "Binders for inhibiting formation of multimeric proteins." This patent, effective March 18, 2026, covers specific biotechnological applications related to protein formation.
What changed
The European Patent Office (EPO) has granted patent EP3861011B1, titled "Binders for inhibiting formation of multimeric proteins." The patent is effective March 18, 2026, and applies to multiple European states.
This grant signifies a new intellectual property right in the field of biotechnology. Companies operating in this sector should be aware of this patent, particularly if their research or products involve inhibiting multimeric protein formation, to ensure compliance with patent law and avoid infringement.
What to do next
- Review patent EP3861011B1 for potential impact on product development or research activities.
Source document (simplified)
BINDERS FOR INHIBITING FORMATION OF MULTIMERIC PROTEINS
Grant EP3861011B1 Kind: B1 Mar 18, 2026
Inventors
KITTEN, Olivier, CINIER, Mathieu, HUET, Simon, CHEVREL, Anne
IPC Classifications
C07K 14/195 20060101AFI20250804BHEP G01N 33/68 20060101ALI20250804BHEP C40B 30/04 20060101ALI20250804BHEP C12N 15/10 20060101ALI20250804BHEP A61K 38/16 20060101ALI20250804BHEP A61K 38/00 20060101ALI20250804BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.